Scientific Opinion of health claim related to vitamin K2 and the normal function of the heart and blood vessels pursuant to Article 13(1)

Scientific Opinion on the substantiation of a health claim related to vitamin K2 and contribution to the normal function of the heart and blood vessels (ID 125, further assessment) pursuant to Article 13(1) of Regulation (EC)

NattoPharma has today been informed by the European Commission that the renewed application for an Article 13.1 claim has been rejected.

About NattoPharma ASA
NattoPharma ASA, Norway is the exclusive international supplier of MenaQ7, the natural vitamin K2. NattoPharma has entered into a multi-year research and development program to substantiate and discover the health benefits of natural vitamin K2 for applications in the exciting marketplace for functional food and health food supplements.

For more information, please visit www.nattopharma.com

About MenaQ7
MenaQ7 provides natural vitamin K2 as a fermentation extract whereby vitamin K2 is manufactured using bascillus subtilis natto. This process has the capacity of producing the highly pure and bio-available form of vitamin K2, menaquinone-7 (MK-7). MenaQ7 is the best documented, commercially available natural vitamin K2 with guaranteed actives and stability, clinical substantiation and international patents granted and pending.

For more information on the health benefits of MenaQ7, please visit www.menaq7.com  

For more information, please contact:

Bertil Anderson, COO

+47 900 91 910